全文获取类型
收费全文 | 1885篇 |
免费 | 112篇 |
国内免费 | 32篇 |
专业分类
化学 | 950篇 |
晶体学 | 2篇 |
力学 | 120篇 |
综合类 | 33篇 |
数学 | 410篇 |
物理学 | 514篇 |
出版年
2024年 | 6篇 |
2023年 | 27篇 |
2022年 | 96篇 |
2021年 | 91篇 |
2020年 | 47篇 |
2019年 | 59篇 |
2018年 | 58篇 |
2017年 | 64篇 |
2016年 | 93篇 |
2015年 | 61篇 |
2014年 | 121篇 |
2013年 | 121篇 |
2012年 | 86篇 |
2011年 | 95篇 |
2010年 | 68篇 |
2009年 | 95篇 |
2008年 | 106篇 |
2007年 | 134篇 |
2006年 | 102篇 |
2005年 | 61篇 |
2004年 | 73篇 |
2003年 | 58篇 |
2002年 | 48篇 |
2001年 | 32篇 |
2000年 | 35篇 |
1999年 | 43篇 |
1998年 | 31篇 |
1997年 | 36篇 |
1996年 | 20篇 |
1995年 | 11篇 |
1994年 | 4篇 |
1993年 | 6篇 |
1992年 | 6篇 |
1991年 | 1篇 |
1990年 | 6篇 |
1989年 | 2篇 |
1988年 | 6篇 |
1987年 | 3篇 |
1986年 | 5篇 |
1985年 | 3篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1981年 | 3篇 |
1979年 | 3篇 |
1971年 | 1篇 |
排序方式: 共有2029条查询结果,搜索用时 31 毫秒
31.
Historically, due to the size and nature of the instrumentation, highly skilled laboratory professionals performed clinical
testing in centralized laboratories. Today’s clinicians demand realtime test data at the point of care. This has led to a
new generation of compact, portable instruments permitting ”laboratory” testing to be performed at or near the patient’s bedside
by nonlaboratory workers who are unfamiliar with testing practices. Poorly controlled testing processes leading to poor quality
test results are an insidious problem facing point of care testing today. Manufacturers are addressing this issue through
instrument design. Providers of clinical test results, regardless of location, working with manufacturers and regulators must
create and manage complete test systems that eliminate or minimize sources of error. The National Committee for Clinical Laboratory
Standards (NCCLS) in its EP18 guideline, ”Quality management for unit-use testing,” has developed a quality management system
approach specifically for test devices used for point of care testing (POCT). Simply stated, EP18 utilizes a ”sources of error”
matrix to identify and address potential errors that can impact the test result. The key is the quality systems approach where
all stakeholders – professionals, manufacturers and regulators – collaboratively seek ways to manage errors and ensure quality. We illustrate the use of one quality systems approach, EP18, as a means to advance the quality of test results at point of
care.
Received: 26 June, 2002 Accepted: 17 July 2002
Presented at the European Conference on Quality in the Spotlight in Medical Laboratories, 7–9 October 2001, Antwerp, Belgium
Abbreviations NCCLS National Committee for Clinical Laboratory Standards (formerly) · POCT point of care testing · QC quality control ·
HACCP hazard analysis critical control points · CLIA clinical laboratory improvement amendments (of 1988)
Correspondence to S. S. Ehrmeyer 相似文献
32.
Development of a multicriteria assessment model for ranking biomass feedstock collection and transportation systems 总被引:1,自引:0,他引:1
Amit Kumar Shahab Sokhansanj Peter C. Flynn 《Applied biochemistry and biotechnology》2006,129(1-3):71-87
This study details multicriteria assessment methodology that integrates economic, social, environmental, and technical factors
in order to rank alternatives for biomass collection and transportation systems. Ranking of biomass collection systems is
based on cost of delivered biomass, quality of biomass supplied, emissions during collection, energy input to the chain operations,
and maturity of supply system technologies. The assessment methodology is used to evaluate alternatives for collecting 1.8×106 dry t/yr based on assumptions made on performance of various assemblies of biomass collection systems is based on cost of
delivered biomass, quality of biomass supplied, emissions during collection, energy input to the chain operations, and maturity
of supply system technologies. The assessment methodology is used to evaluate alternatives for collecting 1.8×106 dry t/yr based on assumptions made on performance of various assemblies of biomass collection systems. A proposed collection
option using loafer/stacker was shown to be the best option followed by ensiling and baling. Ranking of biomass transport
systems is based on cost of biomass transport, emissions during transport, traffic congestion, and maturity of different technologies.
At a capacity of 4×106 dry t/yr, rail transport was shown to be the best option, followed by truck transport and pipeline transport, respectively.
These rankings depend highly on assumed maturity of technologies and scale of utilization. These may change if technologies
such as loafing or ensiling (wet storage) methods are proved to be infeasible for large-scale collection systems. 相似文献
33.
The use of (certified) reference materials and quality control materials can form a suitable basis for evaluating measurement uncertainty of routine measurements. In particular when these materials are used for quality control purposes, it is not always evident how the quality control data can be used in the uncertainty budget of a routine measurement. Current guidance documents on the evaluation of measurement uncertainty and the use of reference materials treat this subject only in part, or in very generic terms. ISO/REMCO has established a new working group that will provide practical guidance and examples on how to use quality control data in the evaluation of measurement uncertainty. A short introduction to the subject is given.
相似文献
Adriaan M. H. van der VeenEmail: Phone: +31-15-2691733Fax: +31-15-2691670 |
34.
Gino Morisi Marina Patriarca Ferdinando Chiodo Anna Minoprio Antonio Menditto 《Mikrochimica acta》1996,123(1-4):281-290
Between 1992 and 1994, a new screening campaign for blood Pb monitoring in the Italian general population was carried out. Since the first campaign (started in 1978, in accomplishment of the European Community Directive 77/312/EEC) a working group of the Laboratory of Clinical Biochemistry at the Italian National Institute of Health (Istituto Superiore di Sanità), as the Reference Centre (RC), has coordinated the activity of various laboratories spread over the national territory. Appropriate quality assurance procedures, including an external quality assessment scheme (EQAS), were elaborated. Within the EQAS, three or four trials were carried out every year. Each laboratory participating in the trial analyzed eight control samples prepared from cow blood at different Pb concentrations. The results obtained by each peripheral laboratory and the RC between 1992 and 1994 have been compared by regression analysis. The same statistical method was adopted to compare the results obtained by each peripheral laboratory and the RC in the duplicate analysis of about 10 per cent of the human samples collected during the 1992–1994 monitoring campaign. There was no evidence of systematic differences between the regression lines obtained on control and human samples. In spite of the lower Pb concentration in the control samples analyzed during the 1992–1994 campaign, the analytical performance of the laboratories was better than that obtained in the previous screening campaign (1985–1986). Blood Pb levels observed in human samples collected between 1992 and 1994, confirm the downward time trend observed in the campaigns carried out in 1978–1979, 1980–1981 and 1985–1986. This study confirms that the results obtained in an EQAS are representative of the actual performance in the analysis of real (human) samples. 相似文献
35.
The robustness testing of a normal-phase liquid chromatographic (LC) method for the determination of R-timolol and other related substances in S-timolol maleate was performed applying a two-level Plackett-Burman design. Two qualitative and five quantitative factors were examined. Two types of responses were considered, qualitative, i.e. chromatographic performance criteria, and quantitative ones. The latter were taken into account to determine if the analytical procedure was robust. The quantitative responses were the contents of R-timolol in two S-timolol maleate samples. Even though some significant factor effects were observed on the qualitative responses, the R-timolol contents were not significantly different from those observed at nominal conditions, which demonstrated the robustness of the procedure.Since the experiments of the Plackett-Burman design can be assimilated to laboratories in an interlaboratory study, uncertainty can be evaluated using the robustness test data. The robustness test was set-up in such a way that the required variances could be estimated. It was shown that the robustness set-up allows estimating the reproducibility uncertainty without performing an interlaboratory study. 相似文献
36.
Autoverification is a process in which computer software will automatically evaluate laboratory test results, verify result integrity, and then release the results to the hospital interface without any technologist intervention. Autoverify release criteria are user defined and can be customized. The process of developing, implementing, and monitoring autoverify is achievable for most test results in laboratory medicine. The use of autoverification will improve result quality, increase revenue, and create faster turn-around times. All of this put together will ultimately lead to improved customer satisfaction. Computers and autoverification are survival tools in the competitive market of laboratory diagnostics services.Presented at the 8th Conference on Quality in the Spotlight, 17–18 March 2003, Antwerp, Belgium 相似文献
37.
On September 1, 1992 all testing sites in the United States were required to comply with the Clinical Laboratory Improvement
Amendments of 1988 (CLIA'88). These regulations, based on both total quality management (TQM) and continuous quality improvement
(CQI) principles, reshaped the environment for more than 90% of laboratories. CLIA'88 represented a revolutionary change by
imposing universal, uniform regulations based on test complexity for all sites examining materials derived from the human
body for the purpose of providing information for the diagnosis, prevention, or treatment of disease. CLIA'88 specifies minimum
requirements for personnel, quality control, and proficiency testing (PT). In addition, laboratories are required to follow
manufacturers' directions and comply with other specified good laboratory practices. PT is mandated for most of the frequently
run analyses and quality assurance requirements integrate the principles of CQI as well as TQM into the regulatory process.
Biannual inspection is integral to CLIA'88, however, laboratories can choose other federally approved ("deemed") professional
organizations, such as the Commission on Office Laboratory Accreditation, the College of American Pathologists, or the Joint
Commission on Accreditation of Healthcare Organization, having standards that meet or exceed those of CLIA'88. CLIA'88 has
still not been finalized. This article discusses the impact and changes since CLIA's implementation in 1992.
Received: 5 October 1998 · Accepted: 20 October 1998 相似文献
38.
Use of non-aqueous capillary electrophoresis for the quality control of commercial saffron samples 总被引:1,自引:0,他引:1
A non-aqueous capillary electrophoresis (NACE) method for quantifying the seven crocin metabolites that are the major biologically active ingredients of saffron was developed. Separation is done by using a fused silica capillary filled with a 12.5 mM H3BO3/37.5 mM sodium tetraborate methanolic solution as background electrolyte. The results obtained were compared with the total index "safranal value", widely used as a quality measure of saffron products. The comparison revealed that the proposed NACE method provides useful information not obtained in the safranal value. Infact, samples with a similar safranal value can contain crocin metabolites in different concentrations and relative proportions. This new method is very useful for quality control in commercial saffron samples. 相似文献
39.
De Boer JL Ritsema R Piso S Van Staden H Van Den Beld W 《Analytical and bioanalytical chemistry》2004,379(5-6):872-880
Two screening methods were developed for rapid analysis of a great number of urine and blood samples within the framework of an exposure check of the population after a firework explosion. A total of 56 elements was measured including major elements. Sample preparation consisted of simple dilution. Extensive quality controls were applied including element addition and the use of certified reference materials. Relevant results at levels similar to those found in the literature were obtained for Co, Ni, Cu, Zn, Sr, Cd, Sn, Sb, Ba, Tl, and Pb in urine and for the same elements except Ni, Sn, Sb, and Ba in blood. However, quadrupole ICP–MS has limitations, mainly related to spectral interferences, for the analysis of urine and blood, and these cause higher detection limits. The general aspects discussed in the paper give it wider applicability than just for analysis of blood and urine—it can for example be used in environmental analysis. 相似文献
40.
This paper describes the validation of an isocratic HPLC method for the assay of voriconazole in tablets. The method employs
a Merck LiChrospher? 100 RP-8 (125 × 4.6 mm I.D., 5 μm particle size) column, with a mobile phase of methanol : triethylamine solutions 0.6 %,
pH 6.0 (50:50, v/v) and UV detection at 255 nm. A linear response (r > 0.9999) was observed in the range of 20.0–100.0 μg mL−1. The method showed good recoveries (average 100.4%) and the relative standard deviation intra and inter-day were ≤ 1.0 %.
Validation parameters as specificity and robustness were also determined. The method can be used for both quality control
assay of voriconazole in tablets and for stability studies as the method separates voriconazole from its degradation products
and tablet excipients. 相似文献